Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease. [PDF]
Alexanian AR, Sorokin A, Duersteler M.
europepmc +1 more source
Neurogrit Gold Attenuates 6-OHDA-Induced Dopaminergic Neurodegeneration in Parkinson's Model of Caenorhabditis elegans by Reducing α-Synuclein Accumulation and Pink/Pdr-1 Driven Mitochondrial Dysfunction. [PDF]
Balkrishna A +6 more
europepmc +1 more source
Role of the sympathetic nervous system in cancer-associated cachexia and tumor progression in tumor-bearing BALB/c mice. [PDF]
Gutierrez-Leal I +7 more
europepmc +1 more source
Engineering Bacopa monnieri for improved bacoside content and its neurological evaluation. [PDF]
Jeena GS +10 more
europepmc +1 more source
Les propriétés neuroprotectrices et autophagiques de l'oleuropéine sur des neurones dopaminergiques soumis à un stress oxydatif [PDF]
Achour, Imène
core
Olfactory Dysfunction in a Novel Model of Prodromal Parkinson's Disease in Adult Zebrafish. [PDF]
Vorhees NW +8 more
europepmc +1 more source
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's Disease. [PDF]
Spinaci A +10 more
europepmc +1 more source
Transcranial direct current stimulation exerts neuroprotective effects in Parkinson's disease by restoring Mlst8-mediated autophagic homeostasis. [PDF]
Tian Z +10 more
europepmc +1 more source
Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology
Oxidopamine (6-hydroxydopamine, 6-OHDA) is a toxin commonly used for the creation of experimental animal models of Parkinson's disease, attention-deficit hyperactivity disorder, and Lesch-Nyhan syndrome. Its exact mechanism of action is not completely understood, although there are many indications that it is related to the generation of reactive ...
Igor, Pantic +4 more
openaire +3 more sources
We demonstrate that a proapoptotic chemical agent, oxidopamine, induces dose dependent changes in chromatin textural patterns which can be quantified using the Gray level co-occurrence matrix (GLCM) method. Peripheral blood (heparin-pretreated) samples were treated with oxidopamine (6-OHDA, 6-hydroxydopamine) to achieve effective concentrations of 100,
Igor, Pantic +3 more
openaire +3 more sources

